Home | Articles
Published on:December 2020
Indian Journal of Pharmaceutical Education and Research, 2020; 54(4):835-842
Review Article | doi:10.5530/ijper.54.4.175

Reduced Pharma Supply Chain in COVID-19: Measures to Reduce India’s Reliance for Active Pharmaceutical Ingredients on China and other Countries

Authors and affiliation (s):

Narendra Vyas*, Ankur Joshi, Sapna Malviya, Anil Kharia

Modern Institute of Pharmaceutical Sciences, Indore, Madhya Pradesh, INDIA.


India, which is called the “world of pharmacy” for being a top supplier of medicines in several countries, can depend on other countries for Active Pharmaceutical Ingredients (API) and other raw materials. Although India is one of the major suppliers of high-quality medicines in several countries, the Indian pharmaceutical industry is highly dependent on China and other countries in terms of raw materials (including the production of essential medicines such as Crocin). These raw materials are called Active Pharmaceutical Ingredients (API), also known as loose drugs. Indian pharmaceutical manufacturers import medicines from China and other countries/regions to account for about 70% of total medicine demand. This article sheds light on the important question of how India depends on other countries to obtain API and other raw materials. Also, the effect of COVID-19 pandemic on the supply chain of bulk drugs, which indirectly affects the pharmaceutical manufacturers. The article concludes that this is the right time for India to remove the dependencies for bulk drugs on china and other countries and start producing their own API in the country itself. COVID-19 situation provides India an opportunity to become a preferred alternate hub for manufacturing APIs and intermediates.

Key words: Active Pharmaceutical Ingredients, Imports of API, Imports from China, COVID-19, Bulk drugs, Opportunity for India.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).


Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs